Lindbrook Capital’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $65.1K | Buy |
1,609
+50
| +3% | +$2.02K | 0.01% | 879 |
|
|
2024
Q4 | $43.4K | Hold |
1,559
| – | – | ﹤0.01% | 880 |
|
|
2024
Q3 | $44.7K | Buy |
1,559
+20
| +1% | +$574 | ﹤0.01% | 874 |
|
|
2024
Q2 | $36.1K | Buy |
1,539
+19
| +1% | +$446 | ﹤0.01% | 932 |
|
|
2024
Q1 | $38.4K | Hold |
1,520
| – | – | ﹤0.01% | 893 |
|
|
2023
Q4 | $35.5K | Buy |
1,520
+51
| +3% | +$1.19K | ﹤0.01% | 893 |
|
|
2023
Q3 | $74.3K | Buy |
1,469
+15
| +1% | +$759 | 0.01% | 553 |
|
|
2023
Q2 | $67.9K | Hold |
1,454
| – | – | 0.01% | 611 |
|
|
2023
Q1 | $55.6K | Sell |
1,454
-56
| -4% | -$2.14K | 0.01% | 660 |
|
|
2022
Q4 | $82.7K | Buy |
1,510
+31
| +2% | +$1.7K | 0.01% | 539 |
|
|
2022
Q3 | $50K | Buy |
1,479
+1,347
| +1,020% | +$45.5K | 0.01% | 639 |
|
|
2022
Q2 | $1K | Buy |
+132
| New | +$1K | ﹤0.01% | 2131 |
|